Position in MRNA
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$28,466,237
+$10,162,591 QoQ
Shares Held
560,359
-9.7% QoQ
Ownership
0.141%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 68.45290251428102.ToString("F0")%
Shared 0.ToString("F0")%
None 31.54709748571898.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RHUMBLINE ADVISERS holds $1,237,848,251 across 287 Biotechnology names. MRNA ranks #10 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
423,140 | $188,948,935 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,781 | $121,907,911 | |
| 3 | INCY |
Incyte Corp
|
693,665 | $65,287,749 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,277 | $64,611,300 | |
| 5 | INSM |
INSMED Inc
|
272,615 | $44,578,004 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
164,542 | $31,106,665 | |
| 7 | EXEL |
Exelixis, Inc.
|
723,931 | $31,049,400 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,113,266 | $30,837,468 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,466,237 | 560,359 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $18,303,646 | 620,673 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,101,681 | 662,086 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $17,184,624 | 622,857 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $16,938,189 | 597,467 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $21,829,624 | 525,003 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $36,482,831 | 545,905 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $69,586,550 | 585,992 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $62,752,331 | 588,892 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $58,091,827 | 584,131 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $60,673,785 | 587,412 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $70,626,127 | 581,285 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $89,254,706 | 581,161 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $105,716,249 | 588,555 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $68,127,845 | 576,134 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $81,490,068 | 570,459 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $95,406,373 | 553,851 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $134,081,121 | 527,920 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $196,604,191 | 510,846 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $81,371,459 | 346,291 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $41,845,203 | 319,551 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $33,198,998 | 317,785 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $22,751,785 | 321,580 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $20,442,858 | 318,375 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $6,948,220 | 231,994 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||